From: Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma
Median ± SD of PR expression (2^-∆Ct)
PR status at day 1
Day 1
Day 15
Control group
PR+
0.05 ± 0.02
0.04 ± 0.06
PR-
0.02 ± 0.00
0.03 ± 0.00
Treated group
0.09 ± 0.07
0.03 ± 0.03*
0.02 ± 0.01
0.03 ± 0.05